Teva Pharmaceutical Industries

Tel Aviv, Israelwww.tevapharm.com1expert edge

Leading multinational pharmaceutical company specializing in generic medicines, complex pharmaceuticals, and specialty therapies, reaching approximately 200 million patients daily across 60 countries.

Why interesting to a deal team

$150M clinical co-development deal demonstrates capacity for large-scale pharma partnerships. Valuable precedent for structuring development collaborations and supply chain integration strategies.

Experts connected to this company

Anshul ThakralLed Launch Therapeutics' $150M clinical co-development deal

Anshul Thakral

Chief Executive Officer

Fortrea

FounderNew York

As Fortrea's new CEO executing a high-stakes CRO turnaround, and a Carlyle-connected biotech dealmaker, he sits at the center of pharma-services consolidation and clinical outsourcing trends.

Sources

Name + firmPrimary
tevapharm.com
Name + firmOther
en.wikipedia.org/wiki/Teva_Pharmaceutical_Industries

Strongest evidenceName + firm2 public sourcesHow the grades work